Latest News

W. Kimryn Rathmell Begins Work as 17th Director of the National Cancer Institute

NCI welcomed W. Kimryn Rathmell, M.D., Ph.D., as the 17th director of the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), on December 18, 2023. A renowned kidney cancer expert and influential leader in cancer research and patient care, Dr. Rathmell was selected by President Biden to succeed Monica M. Bertagnolli, M.D., who left NCI to become the NIH director on November 9, 2023. Read the press release.

Research Highlights: Investigating Ways to Reduce and Avoid Side Effects of Medications for Breast Cancer Risk Reduction

There are multiple approved medications to reduce the risk of breast cancer. However, the chances of those medications causing toxic side effects can lead many people to forego preventive interventions. Two recent studies supported by the NCI Division of Cancer Prevention (DCP) are looking at ways to provide breast cancer risk reduction while reducing the chance of adverse side effects. Read the Cancer Prevention Science Blog.

Following Abnormal Cancer Screening Results, Multi-Level Reminders May Increase Follow-Up

A new study suggests that a simple letter and phone call can help modestly increase the percentage of people who complete follow-up testing after receiving abnormal cancer screening test results. The findings come from an NCI-funded clinical trial of nearly 12,000 people overdue for follow-up testing after an abnormal result on a screening test for breast, lung, cervical, or colorectal cancer. Read the NCI Cancer Currents Blog.

ULACNet Update – December 2023

Highlights from the latest issue of ULACNet Update, a newsletter with programmatic and research updates from the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet) include: A summary of the Annual Meeting held in San Juan, Puerto Rico. Reflections from our site partners in Puerto Rico and the Dominican Republic. Updates to an initiative to enhance community dialogue and site education activities. Read the ULACNet Update.

Upcoming Event

Anti-Inflammatory and Immune Properties of Polyunsaturated Fatty Acids in Colorectal Cancer Prevention

Tuesday, January 16 1:00-2:00 p.m. ET Advanced registration is required Dietary habits have increasingly been recognized as modifiable risk factors in the development of colorectal cancer, with particular attention given to the role of polyunsaturated fatty acids (PUFA). During this webinar with Anwaar Saeed, M.D., you will learn about the potential role of PUFA as a preventive agent against colorectal cancer in Lynch syndrome.

Notice of Funding Opportunities (NOFO): Cancer Prevention and Control

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

NCI invites applications to support investigator-initiated clinical trials that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, healthcare delivery, quality of life, and/or survivorship related to cancer. The proposed studies should also have the potential to improve clinical practice and/or public health.

PAR-24-072

Expires: January 8, 2027

Reminder

Last Chance: Applications for NCI PREVENT Program Due January 8

Applications from researchers with innovative ideas in precision cancer prevention are due January 8. For more information about the NCI PREVENT Program, a list of current projects, and application instructions, visit the PREVENT website.

In case you missed it:

Recording Available: Immune Interception Approaches for Individuals at Risk for Pancreatic Cancer

Missed the December 13, 2023, DCP Immunology Interest Group Seminar Series talk on cancer prevention, interception, and immuno-oncology? Watch the recording.

Do you forward DCP Updates to others?
Encourage them to subscribe.

Read more DCP Updates.

Division of Cancer Prevention

National Cancer Institute    National Institutes of Health    U.S. Department of Health and Human Services